globenewswire news

Transactions under Novonesis’ share buyback program

2026-10-05T13:48:22Z

Please read the announcement in PDF

Attachment

2026_20_Share_buyback

Articles

Legacy Opens Acres Homes Clinic to Expand Access to Care in a Historic Houston Community

2026-10-05T22:34:58Z

New 26,200-square-foot clinic brings coordinated, affordable care under one roof for Acres Homes families

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

2026-10-05T22:00:00Z

BOSTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on October 1, 2026, the Compensation...

Vaxcyte Announces Commencement of Proposed Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes

2026-10-05T20:28:01Z

SAN CARLOS, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that it has commenced underwritten public offerings of $500 million...

Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026

2026-10-05T20:05:00Z

SOUTH SAN FRANCISCO, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver...

Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team

2026-10-05T20:05:00Z

Strengthens leadership team with appointments of John Brottem as general counsel and Amelia Merrill as chief people officer

Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026

2026-10-05T20:05:00Z

MINNEAPOLIS, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2026 after the close of trading on Monday,...

Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED

2026-10-05T20:05:00Z

BOSTON, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the “Company”) today announced it has entered into a definitive agreement to sell its...

Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121

2026-10-05T20:05:00Z

CAMBRIDGE, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company leveraging its oligonucleotide promoted editing of RNA (OPERA®) platform to develop a...

Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504

2026-10-05T20:05:00Z

On track to initiate dosing by early November 2026; topline Phase 1 proof-of-mechanism data anticipated approximately six months following study initiation

Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting

2026-10-05T20:05:00Z

IRVINE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced an oral presentation will be featured at the upcoming American Society of Nephrology Kidney...

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock

2026-10-05T20:01:00Z

WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard...

Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-10-05T20:01:00Z

PHILADELPHIA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specifically for patients...

BridgeBio and Community Partners Launch Nationwide ATTR-CM Education Effort Ahead of World Amyloidosis Day

2026-10-05T20:01:00Z

- October 6 YouTube premiere featuring Sway Calloway, Howard “H” White and leading medical and cultural voices anchors community education nationwide

iCell Gene Therapeutics Announces Upcoming Conference Presentations

2026-10-05T20:01:00Z

STONY BROOK, N.Y., Oct. 05, 2026 (GLOBE NEWSWIRE) -- iCell Gene Therapeutics ("iCell Gene"), a clinical-stage biopharmaceutical company developing autologous and in vivo CAR T cell therapies for autoimmune diseases...

ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development

2026-10-05T20:01:00Z

ORIC-259 is a potential first-in-class small molecule mRNA degrader targeting CIP2A, a previously undruggable target

Major shareholder announcement - BlackRock, Inc.

2026-10-05T19:52:36Z

ANNOUNCEMENT NO. 3185 October 2026

FDA Clears Motivista (CT-155), the First Authorized Treatment for Negative Schizophrenia Symptoms

2026-10-05T19:15:14Z

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Click Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (marketing authorization) for Motivista, a...

Cerene® Cryotherapy Brings Free Mother-Daughter Period Education Brunch to Indianapolis Area

2026-10-05T19:06:29Z

CARMEL, Ind., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Channel Medsystems’ Cerene® Cryotherapy is bringing its Cycles & Seasons Mother-Daughter Brunch to the Indianapolis area on Saturday, October 10, offering local mothers,...

Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

2026-10-05T18:49:00Z

Company Announcement

Baylor Genetics Selected as the Lead Sequencing Partner for Florida’s Sunshine Genetics Pilot Program Launch

2026-10-05T18:05:47Z

The company will provide comprehensive Whole Genome Sequencing for the initial launch of the first statewide genomic newborn screening program

Frederick Breathe Free Celebrates Dr. Jamie Oberman’s Recognition as a 2026 Castle Connolly Top Doctor

2026-10-05T16:59:00Z

Dr. Oberman’s recognition highlights his commitment to thoughtful, patient-centered ENT care at Frederick Breathe Free.